Robert L Ferris Selected Research

Indicators and Reagents (Reagents)

1/2018	Oligometastatic status as predictor of survival in metastatic human papillomavirus-positive oropharyngeal carcinoma.
1/2014	Quantifying metabolic heterogeneity in head and neck tumors in real time: 2-DG uptake is highest in hypoxic tumor regions.
10/2012	Lymphatics, lymph nodes and the immune system: barriers and gateways for cancer spread.
10/2012	Sentinel lymph node biopsy versus selective neck dissection for detection of metastatic oral squamous cell carcinoma.
11/2009	Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neck cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert L Ferris Research Topics

Disease

195	Neoplasms (Cancer) 04/2024 - 11/2003
136	Squamous Cell Carcinoma of Head and Neck 05/2024 - 03/2004
96	Head and Neck Neoplasms (Head and Neck Cancer) 04/2024 - 01/2004
19	Neoplasm Metastasis (Metastasis) 01/2017 - 03/2004
13	Melanoma (Melanoma, Malignant) 03/2024 - 01/2017
13	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 12/2004
13	Carcinogenesis 01/2021 - 03/2005
10	Thyroid Neoplasms (Thyroid Cancer) 05/2022 - 09/2007
9	Disease Progression 01/2023 - 01/2005
9	Carcinoma (Carcinomatosis) 01/2023 - 04/2005
7	Oropharyngeal Neoplasms 10/2022 - 12/2004
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 08/2014
5	Fatigue 03/2024 - 06/2005
5	Deglutition Disorders (Dysphagia) 10/2022 - 01/2010
5	Inflammation (Inflammations) 12/2021 - 01/2006
5	Hemorrhage 01/2021 - 01/2016
4	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 08/2011
4	Infections 01/2021 - 10/2004
4	Squamous Cell Neoplasms (Squamous Cell Cancer) 12/2018 - 09/2014
4	Pemphigus (Pemphigus Vulgaris) 08/2013 - 03/2005
3	Pain (Aches) 01/2023 - 01/2017
3	Mucositis 01/2023 - 01/2010
3	Hypoxia (Hypoxemia) 01/2021 - 01/2014
3	Bites and Stings (Sting) 01/2020 - 01/2018
3	Margins of Excision 01/2018 - 01/2016
3	Sarcoma (Soft Tissue Sarcoma) 04/2017 - 12/2014
2	Dermatitis 03/2024 - 01/2022
2	Extranodal Extension 01/2023 - 01/2018
2	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2014
2	Stomatitis 12/2022 - 10/2017

Drug/Important Bio-Agent (IBA)

47	Cetuximab (Erbitux)FDA Link 03/2024 - 12/2007
35	Biomarkers (Surrogate Marker)IBA 04/2024 - 03/2005
22	Monoclonal AntibodiesIBA 03/2024 - 12/2007
21	Proteins (Proteins, Gene)FDA Link 11/2023 - 10/2004
21	ErbB Receptors (EGF Receptor)IBA 08/2021 - 01/2007
19	NivolumabIBA 03/2024 - 11/2016
15	Neoplasm Antigens (Tumor Antigens)IBA 01/2018 - 10/2004
12	PlatinumIBA 01/2023 - 11/2016
11	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2018
11	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 05/2010
11	CytokinesIBA 01/2018 - 03/2005
10	RNA (Ribonucleic Acid)IBA 11/2023 - 03/2014
10	LigandsIBA 01/2022 - 03/2004
8	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 04/2016
8	VaccinesIBA 01/2022 - 06/2007
8	Peptides (Polypeptides)IBA 07/2018 - 10/2004
8	AntigensIBA 08/2013 - 03/2005
7	Chemokine ReceptorsIBA 01/2012 - 03/2004
6	AntibodiesIBA 12/2019 - 03/2008
6	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019 - 01/2005
6	EpitopesIBA 01/2019 - 11/2005
6	Histocompatibility Antigens Class IIBA 01/2018 - 01/2005
6	ChemokinesIBA 01/2018 - 05/2005
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2017 - 06/2005
5	IpilimumabIBA 01/2023 - 10/2018
5	CarcinogensIBA 01/2022 - 05/2008
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 10/2011
5	Indicators and Reagents (Reagents)IBA 01/2018 - 11/2009
4	Tumor Biomarkers (Tumor Markers)IBA 01/2023 - 11/2009
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023 - 07/2005
4	pembrolizumabIBA 01/2022 - 01/2019
4	B7-H1 AntigenIBA 01/2022 - 03/2016
4	HLA-A*02:01 antigenIBA 07/2018 - 10/2004
4	HLA-A Antigens (HLA-A)IBA 01/2018 - 12/2005
4	Messenger RNA (mRNA)IBA 01/2018 - 05/2005
4	Docetaxel (Taxotere)FDA Link 01/2017 - 12/2010
4	Panitumumab (Vectibix)FDA Link 11/2016 - 12/2007
3	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 01/2019
3	NF-kappa B (NF-kB)IBA 01/2022 - 01/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 03/2014
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 10/2011
3	Small Interfering RNA (siRNA)IBA 01/2021 - 11/2009
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 06/2020 - 10/2008
3	VTX-2337IBA 11/2018 - 08/2013
3	Immunoglobulin G (IgG)IBA 02/2018 - 01/2015
3	InterferonsIBA 01/2018 - 09/2014
3	Phosphotransferases (Kinase)IBA 01/2018 - 09/2005
3	MicroRNAs (MicroRNA)IBA 04/2017 - 04/2011
3	MucinsIBA 03/2017 - 01/2016
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017 - 11/2012
3	Growth Factor ReceptorsIBA 01/2017 - 03/2008
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2016 - 06/2013
3	Codon (Codons)IBA 05/2015 - 10/2010
3	Epidermal Growth Factor (EGF)IBA 10/2014 - 01/2007
3	CalciumIBA 08/2013 - 04/2011
2	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 12/2019
2	Programmed Cell Death 1 ReceptorIBA 01/2023 - 01/2022
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022 - 11/2009
2	Type II Tumor Necrosis Factor ReceptorsIBA 01/2022 - 01/2016
2	SteroidsIBA 01/2022 - 11/2003

Therapy/Procedure

91	Therapeutics 03/2024 - 11/2003
68	Immunotherapy 05/2024 - 01/2004
47	Radiotherapy 01/2024 - 04/2005
26	Drug Therapy (Chemotherapy) 01/2024 - 06/2005
15	Neck Dissection (Radical Neck Dissection) 01/2021 - 12/2004
9	Re-Irradiation 01/2019 - 04/2011
6	Chemoradiotherapy 02/2023 - 01/2010
5	Neoadjuvant Therapy 01/2023 - 11/2012
4	Thyroidectomy 01/2018 - 11/2008
3	Glossectomy 12/2017 - 11/2013